Literature DB >> 22978822

Innate immune responses to TLR2 and TLR4 agonists differ between baboons, chimpanzees and humans.

J F Brinkworth1, E A Pechenkina, J Silver, S M Goyert.   

Abstract

BACKGROUND: African catarrhine primates differ in bacterial disease susceptibility.
METHODS: Human, chimpanzee, and baboon blood were stimulated with TLR-detected bacterial agonists and cytokine/chemokine induction assessed by real-time PCR.
RESULTS: Humans and chimpanzees shared similar cytokine/chemokine responses, while baboon cytokine/chemokine induction differed. Generally, responses were agonist independent.
CONCLUSIONS: These primates tend to generate species rather than agonist-specific responses to bacterial agonists.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22978822      PMCID: PMC3603697          DOI: 10.1111/jmp.12002

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  26 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 2.  TLR4 as the mammalian endotoxin sensor.

Authors:  B Beutler
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

3.  Human macrophage activation programs induced by bacterial pathogens.

Authors:  Gerard J Nau; Joan F L Richmond; Ann Schlesinger; Ezra G Jennings; Eric S Lander; Richard A Young
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.

Authors:  T K Means; B W Jones; A B Schromm; B A Shurtleff; J A Smith; J Keane; D T Golenbock; S N Vogel; M J Fenton
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

5.  Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.

Authors:  O Takeuchi; A Kaufmann; K Grote; T Kawai; K Hoshino; M Morr; P F Mühlradt; S Akira
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

6.  Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research.

Authors:  J A Langermans; P Andersen; D van Soolingen; R A Vervenne; P A Frost; T van der Laan; L A van Pinxteren; J van den Hombergh; S Kroon; I Peekel; S Florquin; A W Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

7.  The evolutionary watershed of susceptibility to gonococcal infection.

Authors:  Z A McGee; C R Gregg; A P Johnson; S S Kalter; D Taylor-Robinson
Journal:  Microb Pathog       Date:  1990-08       Impact factor: 3.738

8.  Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

Authors:  S J van Deventer; H R Büller; J W ten Cate; L A Aarden; C E Hack; A Sturk
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

9.  Lipopolysaccharide dose response in baboons.

Authors:  Sandra B Haudek; Beate E Natmessnig; Walter Fürst; Soheyl Bahrami; Günther Schlag; Heinz Redl
Journal:  Shock       Date:  2003-11       Impact factor: 3.454

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  8 in total

1.  Loss of CMAH during Human Evolution Primed the Monocyte-Macrophage Lineage toward a More Inflammatory and Phagocytic State.

Authors:  Jonathan J Okerblom; Flavio Schwarz; Josh Olson; William Fletes; Syed Raza Ali; Paul T Martin; Christopher K Glass; Victor Nizet; Ajit Varki
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

2.  Thyroid autoantibodies are rare in nonhuman great apes and hypothyroidism cannot be attributed to thyroid autoimmunity.

Authors:  Holly Aliesky; Cynthia L Courtney; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2013-10-03       Impact factor: 4.736

Review 3.  Reservoir host immune responses to emerging zoonotic viruses.

Authors:  Judith N Mandl; Rafi Ahmed; Luis B Barreiro; Peter Daszak; Jonathan H Epstein; Herbert W Virgin; Mark B Feinberg
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

Review 4.  Immunological and technical considerations in application of alginate-based microencapsulation systems.

Authors:  Genaro Alberto Paredes Juárez; Milica Spasojevic; Marijke M Faas; Paul de Vos
Journal:  Front Bioeng Biotechnol       Date:  2014-08-06

5.  Discordant biological and toxicological species responses to TLR3 activation.

Authors:  William M Mitchell; Christopher F Nicodemus; William A Carter; Joseph C Horvath; David R Strayer
Journal:  Am J Pathol       Date:  2014-01-30       Impact factor: 4.307

6.  Primate innate immune responses to bacterial and viral pathogens reveals an evolutionary trade-off between strength and specificity.

Authors:  Mohamed B F Hawash; Joaquin Sanz-Remón; Jean-Christophe Grenier; Jordan Kohn; Vania Yotova; Zach Johnson; Robert E Lanford; Jessica F Brinkworth; Luis B Barreiro
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

Review 7.  A comparative review of toll-like receptor 4 expression and functionality in different animal species.

Authors:  Céline Vaure; Yuanqing Liu
Journal:  Front Immunol       Date:  2014-07-10       Impact factor: 7.561

Review 8.  TLR4 Signaling by Heme and the Role of Heme-Binding Blood Proteins.

Authors:  Sabina Janciauskiene; Vijith Vijayan; Stephan Immenschuh
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.